Elva Ni and Phil Lam Help Rare Disease Teen Realize His Dream
Support Community Med Care's Free Traditional Chinese Medicine Program for Children
HONG KONG, June 13, 2025 /PRNewswire/ -- Community Med Care proudly launches the first episode of its new YouTube documentary series "Elva's Dream Series", created in collaboration with ambassador Elva Ni. After nearly a year of preparation and filming, each episode highlights a child receiving treatment under the "Stand Up with Love: Angel Mission" program — a Traditional Chinese Medicine (TCM) initiative offering free consultations to children with rare diseases, autism, or brain disorders. With Elva's full support, the children pursue and accomplish what once seemed like impossible dreams.
Download high-resolution images: https://shorturl.at/V2AG7
In the debut episode, Elva teams up with singer-songwriter Phil Lam to help a teenage boy with a rare disease, Tsz Kin, realize his dream of composing music. Elva hopes these stories will inspire others not to give up and calls on the public to support the "Angel Mission", which brings TCM care and new hope to children facing serious medical conditions.
Elva Ni and Phil Lam Help Teen with Muscular Dystrophy Compose His First Song
The first episode features 16-year-old Tsz Kin, who suffers from Duchenne Muscular Dystrophy, a rare and currently incurable disease. The condition affects approximately 1 in 5,000 individuals, currently has no cure, and the average life expectancy for patients is 18 years. Diagnosed at just 18 months old, Tsz Kin began using a wheelchair in 2018 as his muscles weakened. Since 2019, he has been receiving weekly acupuncture treatments through the "Angel Mission", which have helped relieve the deterioration in his hands and muscle strength.
A passionate music lover, Tsz Kin had always dreamed of learning to compose. With Elva's encouragement and guidance, he began studying composition and arrangement from scratch. Elva even gifted him an electric keyboard to fuel his creativity, becoming his "muse" along the way. After months of hard work, Tsz Kin completed the first draft of his debut song. Deeply moved by his journey, Phil Lam happily agreed to mentor him further. The episode concludes with Tsz Kin, Elva, and Phil co-performing the completed piece — a moment of joy and triumph for the aspiring young composer, who expressed his heartfelt gratitude to both Elva and Phil for their support.
Children with Autism Become a Princess and Shop Assistant
The second and third episodes of "Elva's Dream Series" focus on children with autism. The second episode features 14-year-old Sze Wai, who has long dreamed of becoming a Disney princess. After listening carefully to her story, Elva personally did Sze Wai's makeup, helping her transform into Belle from "Beauty and the Beast". Sze Wai's radiant smile spoke volumes about her happiness.
In the third episode, we meet Kai Man, another young girl with autism who dreams of becoming a confident, independent shop assistant. With support from her mother and Elva, she bravely faced the challenges posed by speech difficulties and got a chance to experience her dream job.
"Stand Up with Love: Angel Mission" Brings Free TCM to Children in Need
Founded in October 2018 by Professor Wong Tin Chee, Community Med Care is a charity organization providing free TCM care, especially bone-setting treatments, to children and youth (ages 0–30) with congenital or acquired brain damage, autism, Down syndrome, rare diseases, and more. The "Stand Up with Love: Angel Mission" is its flagship initiative, celebrating its 7th anniversary this year.
To mark the occasion, ambassador Elva Ni created the "Elva's Dream Series" mini-documentary in partnership with the organization. Each episode follows a child's journey — understanding their daily life, challenges, and dreams, and helping them achieve what once seemed unreachable.
Elva's Dream Series
This seven-episode mini-documentary series premieres on June 13, 2025, and will air on the second Friday of each month at 5 PM on Elva Ni's official YouTube channel (https://www.youtube.com/@misselvani ).
Support the "Stand Up with Love: Angel Mission" Monthly Donation Program
We invite you to join our monthly giving campaign to support children like Tsz Kin, Sze Wai, and Kai Man in receiving free TCM care and continuing to pursue their dreams.
Just HKD$200 can fund one acupuncture session for a child in need — a small act that helps bring light into the darkness of chronic illness.
Donation details and link: https://shorturl.at/0vRbv
About Community Med Care:
Established in October 2018 by Professor Wong Tin Chee (Charity Tax Registration No.: 91/17034), Community Med Care's "Angel Mission" provides free long-term rehabilitation services for children with autism, congenital and acquired brain injuries, and rare diseases. We also offer health training for parents of disabled children to help them better care for their children's health needs.
Community Med Care's vision is to provide rehabilitation services to those battling illness with limited resources, reigniting their hopes and dreams. From 2019 to 2024, the "Angel Mission" has provided over 41,579 free treatments to more than 1,046 children and adolescents with brain diseases or cerebral palsy. We believe everyone deserves equal access to medical and rehabilitation services and will continue to expand our reach and impact to help more in need, restoring their health and rekindling their hopes and dreams for the future.For more information about Community Med Care, please visit:
Website: https://communitymedcare.org/
Facebook: https://www.facebook.com/communitymedcareorg
Instagram: https://www.instagram.com/communitymedcareorg/
About Professor Wong Tin Chee:
A member of a prominent medical family in Hong Kong, Professor Wong has dedicated over 50 years to promoting the unique culture of traditional medicine in Hong Kong. Inspired by his father, he has a passion for research and has inherited his father's wisdom and expertise, embodying the principles of "treating the root of illness" and "using pain as a point of treatment." Professor Wong is a leading expert in pediatric brain diseases and established Community Med Care to provide rehabilitation services for children with brain conditions.
Media Inquiries:
Community Med CarePhone: (852) 3997 3868Email: info@communitymedcare.orgMedia Contact:info@sortieagency.com
View original content to download multimedia:https://www.prnewswire.com/apac/news-releases/elva-ni-and-phil-lam-help-rare-disease-teen-realize-his-dream-302480873.html
SOURCE Community Med Care
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
2 hours ago
- Yahoo
Defibrillator Market worth US$16.44 billion by 2030 with 6.5% CAGR
DELRAY BEACH, Fla., Aug. 13, 2025 /PRNewswire/ -- The global Defibrillator Market, valued at US$11.29 billion in 2024, stood at US$11.99 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$16.44 billion by the end of the period. The growth in the defibrillator market is attributed to the increase in the prevalence of cardiovascular diseases, the increasing adult population with higher susceptibility to cardiac arrest, a strong focus of government organizations to enhance the accessibility of defibrillators by boosting the installation of public access defibrillators and providing training & programs on defibrillators. Additionally, the rapid expansion of healthcare infrastructure in emerging countries and strategic collaborations & partnerships among manufacturers to boost the new developments in defibrillators are likely to support the market's growth in the near future. Download PDF Brochure: Browse in-depth TOC on "Defibrillator Market" 337 - Tables57 - Figures296 - Pages By product, the defibrillators market is broadly segmented into implantable cardioverter defibrillators (ICDs) and external defibrillators. The implantable cardioverter defibrillators (ICDs) segment is anticipated to capture the largest global defibrillator market share by product in 2024. Timely intervention using implantable defibrillators during cardiac emergencies is a key advantage offered by this programmed device. Moreover, growing approvals of technologically advanced implantable defibrillators and rising preference for subcutaneous ICDs are likely to support the growth of this segment during the forecast period. By end users, the defibrillators market is segmented into Hospitals & Clinics, Cardiac Centers, Pre-hospital Settings, Public-Access Markets, Home Care Settings, and Other End Users. The hospitals & clinics segment dominated the global defibrillators market in 2024. The significant rise in hospitalization for critical cardiac conditions, the growing number of ICD and CRT-D implant procedures performed in hospitals, and the rising prevalence of cardiac diseases among geriatric patients are the major factors boosting the demand for defibrillators among target end-user segments during the study period. By geography, the defibrillator market is segmented based on the region into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for the largest share of the defibrillator market. This can be attributed to the rapid adoption of technologically advanced defibrillators, favorable reimbursement policy, and the strong presence of manufacturers with a strong focus on strengthening R&D through investments in new product development. Asia Pacific is expected to grow at the highest CAGR during the forecast period owing to the presence of a large target patient pool, government initiatives to modernize & expand healthcare infrastructure, and expansion of market players in the region. Request Sample Pages : Major players in the defibrillator market include Medtronic (Ireland), Stryker (US), Koninklijke Philips N.V. (Netherlands), Asahi Kasei Corporation (Japan), Boston Scientific Corporation (US), Abbott (US), MicroPort Scientific Corporation (China), Nihon Kohden Corporation (Japan), Biotronik (Germany), and CU Medical Systems, Inc. (South Korea). MEDTRONIC: MEDTRONIC Due to its extensive product portfolio, Medtronic is the leading player in the global implantable defibrillator market. The company primarily focuses on developing innovative products to treat and manage heart failure and heart rhythm disorders. The company focuses on inorganic business growth strategies such as product development & commercialization, acquisitions, and market expansions to strengthen its current position and gain a larger share of the neurovascular devices market. The company received the CE Mark for its implantable defibrillator systems, Aurora EV-ICD MRI SureScan and Epsila EV MRI SureScan for managing irregular heart rhythms. Moreover, the company is also focusing on expanding its R&D capabilities to fuel product development and commercialization across mature and emerging markets. Koninklijke Philips N.V. Koninklijke Philips N.V. is a key player in the global defibrillator market, driven by its widely adopted HeartStart AED series. The company has established a strong presence through user-friendly, reliable devices designed for both public and professional use. Philips continues to lead with innovations such as real-time guidance, fast shock delivery, and connected care capabilities. Its strategic focus on accessibility, digital integration, and global deployment has reinforced its role in advancing out-of-hospital cardiac care. Boston Scientific Corporation Boston Scientific Corporation focuses on innovation and product launches in cardiac rhythm management to provide advanced solutions to healthcare professionals to improve the quality of life. The company continuously invests in R&D to launch new & innovative products. Boston Scientific primarily pursues the strategy of new product launches to sustain its position in the global defibrillators market. Regulatory approvals for its MRI-compatible defibrillators and technological advancements are expected to help the company maintain its position in the market. For more information, Inquire Now! Related Reports: Refurbished Medical Equipment Market IoT Medical Devices Market Cardiac Monitoring & Cardiac Rhythm Management Devices Market Respiratory Care Devices Market Top 10 Medical Device Technologies Market Get access to the latest updates on Defibrillator Companies and Defibrillator Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter, LinkedIn and Facebook. Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets
Yahoo
2 hours ago
- Yahoo
InventHelp Inventor Develops Organic Formula to Reduce Pain (HWT-601)
PITTSBURGH, Aug. 13, 2025 /PRNewswire/ -- "I thought there could be an all-organic formula to assist with pain relief and stiffness in various areas of the body," said an inventor, from Rock Creek, Ohio, "so I invented the PAIN AWAY. My formula works quickly to reduce pain, inflammation, and discomfort." The patent-pending invention provides an all-organic formula to aid in the treatment of pain caused by various ailments such as arthritis, back pain, restless leg syndrome, etc. In doing so, it helps relieve pain and discomfort. It also could increase mobility. The invention features an effective formula that is easy to apply so it is ideal for individuals with arthritis, back pain, etc. The original design was submitted to the National sales office of InventHelp. It is currently available for licensing or sale to manufacturers or marketers. For more information, write Dept. 24-HWT-601, InventHelp, 100 Beecham Drive, Suite 110, Pittsburgh, PA 15205-9801, or call (412) 288-1300 ext. 1368. Learn more about InventHelp's Invention Submission Services at View original content to download multimedia: SOURCE InventHelp
Yahoo
2 hours ago
- Yahoo
2025 CHINA FOCUS Returns to Edinburgh Festivals Showcasing Cutting-Edge Chinese Performing Arts
EDINBURGH, Scotland, Aug. 12, 2025 /PRNewswire/ -- The acclaimed CHINA FOCUS has officially launched its return to the Edinburgh International Festival and Edinburgh Festival Fringe in 2025 for the fifth edition, presenting nine groundbreaking productions from China. This year's programme (30 July – 25 August) highlights the dynamism and diversity of contemporary Chinese creativity across music, dance, theatre, and experimental performance. Notably, the Edinburgh International Festival hosted the debut of the China National Centre for the Performing Arts Orchestra in Bruce Liu Plays Ravel (6 August, Usher Hall), conducted by Myung-whun Chung with pianist Liu Xiaoyu, presenting Chen Qigang's Wu Xing alongside Ravel and Saint-Saëns. Eight productions ignites the Edinburgh Festival Fringe: Personallery 4.0 (Shanghai University of Sport) fuses ballroom dance and AI to reimagine The Peony Pavilion, Youth and Poetry (QFun Theatre) transforms The Book of Songs into children's musical theatre, Zhuangzi's Dream (Central Academy of Drama) weaves shadow puppetry and Daoist philosophy, The Vast Lament: The Floating Life Performance (Spectator Concept Theatre) crafts an AI-augmented metaphysical journey, Inspired by the Eastern Wind (Shanghai Institute of Visual Arts) interprets classical strategy through street dance, The Pure Blue (Shanghai Theatre Academy) evokes ocean conservation via ethereal movement, Echoes (China Coal Mine Art Troupe) resurrects the legend of Ji Kang through musical drama, and Hibiscus and the Thistle (Hunan Song and Dance Theatre) unites Chinese traditional instruments with Western classics. Since its inception in 2017, CHINA FOCUS has showcased 35 productions to over 120,000 Edinburgh audiences, continually blending tradition with contemporary artistry. Organised by China Shanghai International Arts Festival, co-organised by Branding Shanghai and with the support of Chinese Ministry of Culture and Tourism, Chinese Embassy in the UK, Shanghai Municipal Administration of Culture and Tourism, and Information Office of Shanghai Municipality, the initiative aims to elevate Chinese narratives on the global stage. Media Contact: Jennifer Qianjqian@ View original content: SOURCE Branding Shanghai Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
